当前位置:首页 - 行情中心 - 天坛生物(600161) - 财务分析

天坛生物

(600161)

  

流通市值:338.92亿  总市值:338.92亿
流通股本:19.77亿   总股本:19.77亿

天坛生物(600161)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润11.20亿元,每股收益0.41元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1494704.33万元,未分配利润667877.10万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1655087.33万元,负债160383.00万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入4,465,071,868.983,110,392,965.341,317,766,404.916,031,865,460.16
营业总成本3,110,810,892.922,079,476,311.38908,034,937.263,517,680,781.42
其他经营收益
营业利润1,354,283,536.851,041,961,680.23406,247,067.262,557,785,310.27
利润总额1,347,397,281.361,038,370,155.27406,278,490.582,547,217,502.79
净利润1,120,457,127.99865,800,086.14337,283,020.122,112,264,516.35
每股收益
其他综合收益---19,095,716.14
综合收益总额1,120,457,127.99865,800,086.14337,283,020.122,131,360,232.49
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计8,271,318,830.988,265,558,876.448,054,263,131.797,722,300,180.61
非流动资产:
非流动资产合计8,279,554,513.918,256,258,173.318,181,080,667.838,147,222,036.95
资产总计16,550,873,344.8916,521,817,049.7516,235,343,799.6215,869,522,217.56
流动负债:
流动负债合计1,375,250,314.291,293,239,592.011,120,502,082.121,120,345,416.74
非流动负债:
非流动负债合计228,579,686.6238,439,458.81244,360,116.76215,978,220.2
负债合计1,603,830,000.891,531,679,050.821,364,862,198.881,336,323,636.94
所有者权益(或股东权益):
归属于母公司股东权益合计11,463,047,833.7611,573,529,356.3111,382,850,030.2611,138,704,354.81
股东权益合计14,947,043,34414,990,137,998.9314,870,481,600.7414,533,198,580.62
负债和股东权益合计16,550,873,344.8916,521,817,049.7516,235,343,799.6215,869,522,217.56
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,158,646,299.761,786,497,499.46703,003,919.445,065,423,421.85
经营活动现金流出小计3,041,751,271.691,988,402,049.581,004,643,632.644,245,642,716.76
经营活动产生的现金流量净额116,895,028.07-201,904,550.12-301,639,713.2819,780,705.09
投资活动产生的现金流量:
投资活动现金流入小计737,239,185.26737,180,887.6652,446.71,046,990,249.3
投资活动现金流出小计450,530,338.98325,460,519.56144,405,613.982,906,106,439.81
投资活动产生的现金流量净额286,708,846.28411,720,368.1-144,353,167.28-1,859,116,190.51
筹资活动产生的现金流量:
筹资活动现金流入小计252,966,301.4242,137,862.6334,737,094.71-
筹资活动现金流出小计725,128,995.46315,178,569.812,068,648.47370,286,842.87
筹资活动产生的现金流量净额-472,162,694.04-273,040,707.1832,668,446.24-370,286,842.87
汇率变动对现金及现金等价物的影响-9,499.67-2,279.48370.01-43,795.73
现金及现金等价物净增加额-68,568,319.36-63,227,168.68-413,324,064.23-1,409,666,124.02
期末现金及现金等价物余额1,354,352,585.681,359,693,736.361,009,596,840.811,422,920,905.04
补充资料:
现金及现金等价物的净增加额--63,227,168.68--1,409,666,124.02
最新报告期:2025-10-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券孙媛媛,黄翰漾0.630.811.002025-10-28
中国银河程培,宋丽莹0.660.760.882025-10-24
兴业证券孙媛媛,黄翰漾0.690.851.002025-09-11
中信证券陈竹,王凯旋,韩世通0.800.901.072025-09-10
TOP↑